MTNB
Matinas BioPharma Holdings, Inc.
Price Chart
Latest Quote
$0.65
+0.02 (+3.03%)
Current Price
| Previous Close | $0.63 |
| Open | $0.64 |
| Day High | $0.67 |
| Day Low | $0.63 |
| Volume | 45,001 |
Stock Information
| Shares Outstanding | 6.41M |
| Total Debt | $1.19M |
| Cash Equivalents | $2.40M |
| Net Income | $-11.23M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market Cap | $4.16M |
| EPS (TTM) | $-1.97 |
| Exchange | ASE |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $2.96M |
| Income | $-11.23M |
| Book/sh | $0.47 |
| Cash/sh | $0.37 |
| Employees | 2 |
Financial Ratios
| Quick Ratio | 1.13 |
| Current Ratio | 1.32 |
| Debt/Eq | 39.34 |
Returns & Margins
| ROA | -48.51% |
| ROE | -228.37% |
Ownership
| Insider Ownership | 22.11% |
| Institutional Ownership | 5.68% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -0.22 |
| P/B | 1.38 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $0.76 |
| SMA50 | $0.66 |
| SMA200 | $0.91 |
| RSI | 34.32 |
| ATR | 0.0749 |
| Shares Float | 5.23M |
| Short Float | 1.08% |
| Short Ratio | 0.20 |
| Volatility | 1.68 |
| Rel Volume | 0.64 |
Performance History
| Week | -13.56% |
| Month | -2.99% |
| Quarter | +1.56% |
| 6 Months | -16.13% |
| YTD | +4.84% |
| Year | -28.81% |
| 3 Years | -96.49% |
| 5 Years | -98.58% |
| 10 Years | -98.02% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-23 | $0.65 | 45,400 |
| 2026-06-22 | $0.63 | 27,300 |
| 2026-06-18 | $0.60 | 60,600 |
| 2026-06-17 | $0.71 | 102,800 |
| 2026-06-16 | $0.72 | 112,000 |
| 2026-06-15 | $0.75 | 40,300 |
| 2026-06-12 | $0.78 | 27,200 |
| 2026-06-11 | $0.81 | 36,100 |
| 2026-06-10 | $0.80 | 50,400 |
| 2026-06-09 | $0.80 | 112,500 |
| 2026-06-08 | $0.82 | 88,200 |
| 2026-06-05 | $0.79 | 24,500 |
| 2026-06-04 | $0.80 | 11,000 |
| 2026-06-03 | $0.78 | 91,300 |
| 2026-06-02 | $0.77 | 217,200 |
| 2026-06-01 | $0.87 | 140,800 |
| 2026-05-29 | $0.81 | 40,400 |
| 2026-05-28 | $0.80 | 56,800 |
| 2026-05-27 | $0.73 | 34,300 |
| 2026-05-26 | $0.73 | 110,300 |
About Matinas BioPharma Holdings, Inc.
Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, identifies and develops pharmaceutical products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nanocrystals for the delivery of small molecules, nucleic acids, gene therapies, vaccines, proteins, and peptides. Its lead product candidate is MAT2203, an oral formulation of amphotericin B that is starting Phase 3 clinical trials for the treatment of aspergillosis and cryptococcosis, as well as prevention of invasive fungal infections in patients due to immunosuppressive therapy. It offers MAT2501, an orally administered formulation of amikacin. The company was incorporated in 2013 and is based in Bedminster, New Jersey.
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Total Revenue | $0 | $0 | $1,096,000 | $3,188,000 |
| Operating Revenue | $0 | $0 | $1,096,000 | $3,188,000 |
| Expenses | ||||
| Total Expenses | $6,960,000 | $20,162,000 | $24,862,000 | $27,778,000 |
| Other Income Expense | $-3,385,000 | $-4,169,000 | $824,000 | $3,593,000 |
| Other Non Operating Income Expenses | $-261,000 | $262,000 | $340,000 | $102,000 |
| Operating Expense | $6,960,000 | $20,162,000 | $24,862,000 | $27,778,000 |
| General And Administrative Expense | $6,875,000 | $8,729,000 | $10,373,000 | $11,100,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-10,345,000 | $-24,251,000 | $-22,942,000 | $-20,997,000 |
| Normalized Income | $-7,221,000 | $-19,834,622 | $-23,426,000 | $-24,488,000 |
| Net Income From Continuing And Discontinued Operation | $-10,345,000 | $-24,251,000 | $-22,942,000 | $-20,997,000 |
| Total Operating Income As Reported | $-6,960,000 | $-24,593,000 | $-23,766,000 | $-24,590,000 |
| Net Income Common Stockholders | $-10,963,000 | $-24,251,000 | $-22,942,000 | $-20,997,000 |
| Net Income | $-10,345,000 | $-24,251,000 | $-22,942,000 | $-20,997,000 |
| Net Income Including Noncontrolling Interests | $-10,345,000 | $-24,251,000 | $-22,942,000 | $-20,997,000 |
| Net Income Continuous Operations | $-10,345,000 | $-24,251,000 | $-22,942,000 | $-20,997,000 |
| Pretax Income | $-10,345,000 | $-24,331,000 | $-22,942,000 | $-20,997,000 |
| Special Income Charges | $37,000 | $-4,431,000 | $484,000 | $3,491,000 |
| Operating Income | $-6,960,000 | $-20,162,000 | $-23,766,000 | $-24,590,000 |
| Per Share | ||||
| Diluted EPS | $-2.00 | $-4.98 | $-5.28 | $-5.00 |
| Basic EPS | $-2.00 | $-4.98 | $-5.28 | $-5.00 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $-14,622 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-3,380,000 | $-14,759,000 | $-23,309,000 | $-27,183,000 |
| Total Unusual Items | $-3,124,000 | $-4,431,000 | $484,000 | $3,491,000 |
| Total Unusual Items Excluding Goodwill | $-3,124,000 | $-4,431,000 | $484,000 | $3,491,000 |
| Reconciled Depreciation | $456,000 | $972,000 | $941,000 | $898,000 |
| EBITDA (Bullshit earnings) | $-6,504,000 | $-19,190,000 | $-22,825,000 | $-23,692,000 |
| EBIT | $-6,960,000 | $-20,162,000 | $-23,766,000 | $-24,590,000 |
| Diluted Average Shares | $5,474,129 | $4,865,829 | $4,345,291 | $4,336,228 |
| Basic Average Shares | $5,474,129 | $4,865,829 | $4,345,291 | $4,336,228 |
| Diluted NI Availto Com Stockholders | $-10,963,000 | $-24,251,000 | $-22,942,000 | $-20,997,000 |
| Otherunder Preferred Stock Dividend | $618,000 | $0 | - | - |
| Tax Provision | $0 | $-80,000 | $0 | - |
| Gain On Sale Of Ppe | $37,000 | $0 | - | - |
| Impairment Of Capital Assets | $0 | $4,431,000 | $0 | - |
| Gain On Sale Of Security | $-3,161,000 | - | - | - |
| Research And Development | $85,000 | $11,433,000 | $14,489,000 | $16,678,000 |
| Selling General And Administration | $6,875,000 | $8,729,000 | $10,373,000 | $11,100,000 |
| Other Gand A | $6,875,000 | $8,729,000 | $10,373,000 | $11,100,000 |
| Gain On Sale Of Business | - | $0 | $484,000 | $3,491,000 |
| Preferred Stock Dividends | - | - | - | - |
Fetched: 2026-06-21
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $2,570,000 | $5,330,000 | $14,893,000 | $32,284,000 |
| Total Assets | $7,208,000 | $12,641,000 | $25,104,000 | $44,819,000 |
| Total Non Current Assets | $3,133,000 | $4,616,000 | $9,561,000 | $10,287,000 |
| Other Non Current Assets | $200,000 | $200,000 | $200,000 | $200,000 |
| Goodwill And Other Intangible Assets | $2,260,000 | $2,260,000 | $4,353,000 | $4,353,000 |
| Other Intangible Assets | $2,260,000 | $2,260,000 | $3,017,000 | $3,017,000 |
| Current Assets | $4,075,000 | $8,025,000 | $15,543,000 | $34,532,000 |
| Other Current Assets | $26,000 | $691,000 | $1,737,000 | $5,719,000 |
| Restricted Cash | $50,000 | $50,000 | $50,000 | $50,000 |
| Cash Cash Equivalents And Short Term Investments | $3,999,000 | $7,284,000 | $13,756,000 | $28,763,000 |
| Cash And Cash Equivalents | $3,999,000 | $7,284,000 | $4,787,000 | $6,830,000 |
| Prepaid Assets | - | - | - | - |
| Debt | ||||
| Total Debt | $1,354,000 | $2,894,000 | $3,556,000 | $4,124,000 |
| Long Term Debt And Capital Lease Obligation | $658,000 | $2,128,000 | $2,895,000 | $3,555,000 |
| Current Debt And Capital Lease Obligation | $696,000 | $766,000 | $661,000 | $569,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $2,378,000 | $5,051,000 | $5,858,000 | $8,182,000 |
| Total Non Current Liabilities Net Minority Interest | $915,000 | $2,385,000 | $3,236,000 | $3,896,000 |
| Non Current Deferred Liabilities | $257,000 | $257,000 | $341,000 | $341,000 |
| Non Current Deferred Taxes Liabilities | $257,000 | $257,000 | $341,000 | $341,000 |
| Current Liabilities | $1,463,000 | $2,666,000 | $2,622,000 | $4,286,000 |
| Payables And Accrued Expenses | $767,000 | $391,000 | $1,961,000 | $2,908,000 |
| Payables | $315,000 | $95,000 | $514,000 | $618,000 |
| Accounts Payable | $315,000 | $95,000 | $514,000 | $618,000 |
| Other Current Liabilities | - | $4,000 | $271,000 | $585,000 |
| Current Deferred Liabilities | - | - | $0 | $809,000 |
| Equity | ||||
| Common Stock Equity | $4,830,000 | $7,590,000 | $19,246,000 | $36,637,000 |
| Total Equity Gross Minority Interest | $4,830,000 | $7,590,000 | $19,246,000 | $36,637,000 |
| Stockholders Equity | $4,830,000 | $7,590,000 | $19,246,000 | $36,637,000 |
| Retained Earnings | $-210,787,000 | $-199,824,000 | $-175,573,000 | $-152,631,000 |
| Gains Losses Not Affecting Retained Earnings | - | $0 | $-221,000 | $-824,000 |
| Other Equity Adjustments | - | - | $-221,000 | $-824,000 |
| Other | ||||
| Ordinary Shares Number | $6,406,191 | $5,086,985 | $4,345,290 | $4,345,290 |
| Share Issued | $6,406,191 | $5,086,985 | $4,345,290 | $4,345,290 |
| Tangible Book Value | $2,570,000 | $5,330,000 | $14,893,000 | $32,284,000 |
| Invested Capital | $4,830,000 | $7,590,000 | $19,246,000 | $36,637,000 |
| Working Capital | $2,612,000 | $5,359,000 | $12,921,000 | $30,246,000 |
| Capital Lease Obligations | $1,354,000 | $2,894,000 | $3,556,000 | $4,124,000 |
| Total Capitalization | $4,830,000 | $7,590,000 | $19,246,000 | $36,637,000 |
| Additional Paid In Capital | $215,616,000 | $207,413,000 | $195,040,000 | $190,070,000 |
| Capital Stock | $1,000 | $1,000 | $0 | $22,000 |
| Common Stock | $1,000 | $1,000 | $0 | $22,000 |
| Preferred Stock | $0 | $0 | - | - |
| Long Term Capital Lease Obligation | $658,000 | $2,128,000 | $2,895,000 | $3,555,000 |
| Current Capital Lease Obligation | $696,000 | $766,000 | $661,000 | $569,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $0 | $1,509,000 | - | - |
| Current Accrued Expenses | $452,000 | $296,000 | $1,447,000 | $2,290,000 |
| Net PPE | $673,000 | $2,156,000 | $5,008,000 | $5,734,000 |
| Accumulated Depreciation | $-28,000 | $-2,060,000 | $-1,695,000 | $-1,369,000 |
| Gross PPE | $701,000 | $4,216,000 | $6,703,000 | $7,103,000 |
| Leases | $166,000 | $993,000 | $1,155,000 | $1,155,000 |
| Other Properties | $535,000 | $3,223,000 | $5,548,000 | $5,948,000 |
| Properties | $0 | $0 | $0 | $0 |
| Goodwill | - | $0 | $1,336,000 | $1,336,000 |
| Other Short Term Investments | - | $0 | $8,969,000 | $21,933,000 |
| Treasury Shares Number | - | - | $0 | - |
| Current Deferred Revenue | - | - | $0 | $721,000 |
Fetched: 2026-06-21
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-7,011,000 | $-15,885,000 | $-15,496,000 | $-20,048,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-7,011,000 | $-15,885,000 | $-15,278,000 | $-19,156,000 |
| Cash Flow From Continuing Operating Activities | $-7,011,000 | $-15,885,000 | $-15,278,000 | $-19,156,000 |
| Operating Gains Losses | $3,365,000 | - | $1,000 | $2,000 |
| Investing Activities | ||||
| Investing Cash Flow | $335,000 | $9,208,000 | $13,242,000 | $4,877,000 |
| Cash Flow From Continuing Investing Activities | $335,000 | $9,208,000 | $13,242,000 | $4,877,000 |
| Net Other Investing Changes | $335,000 | - | - | - |
| Capital Expenditure | - | - | $-218,000 | $-892,000 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $3,300,000 | $9,179,000 | $0 | $0 |
| Financing Cash Flow | $3,391,000 | $9,174,000 | $-7,000 | $79,000 |
| Cash Flow From Continuing Financing Activities | $3,391,000 | $9,174,000 | $-7,000 | $79,000 |
| Net Other Financing Charges | $-29,000 | - | - | - |
| Net Preferred Stock Issuance | $3,300,000 | $0 | - | - |
| Preferred Stock Issuance | $3,300,000 | $0 | - | - |
| Net Common Stock Issuance | $0 | $9,179,000 | $0 | $0 |
| Common Stock Issuance | $0 | $9,179,000 | $0 | $0 |
| Other | ||||
| Repayment Of Debt | $-9,000 | $-5,000 | $-7,000 | $-20,000 |
| End Cash Position | $4,249,000 | $7,534,000 | $5,037,000 | $7,080,000 |
| Beginning Cash Position | $7,534,000 | $5,037,000 | $7,080,000 | $21,280,000 |
| Changes In Cash | $-3,285,000 | $2,497,000 | $-2,043,000 | $-14,200,000 |
| Proceeds From Stock Option Exercised | $129,000 | $0 | $0 | $99,000 |
| Net Issuance Payments Of Debt | $-9,000 | $-5,000 | $-7,000 | $-20,000 |
| Net Long Term Debt Issuance | $-9,000 | $-5,000 | $-7,000 | $-20,000 |
| Long Term Debt Payments | $-9,000 | $-5,000 | $-7,000 | $-20,000 |
| Net Investment Purchase And Sale | $0 | $9,208,000 | $13,460,000 | $5,769,000 |
| Sale Of Investment | $0 | $17,645,000 | $13,460,000 | $15,250,000 |
| Purchase Of Investment | $0 | $-8,437,000 | $0 | $-9,481,000 |
| Change In Working Capital | $-1,510,000 | $-131,000 | $1,667,000 | $-4,789,000 |
| Change In Other Current Liabilities | $-1,042,000 | $-655,000 | $-562,000 | $-520,000 |
| Change In Payables And Accrued Expense | $-1,133,000 | $-63,000 | $-1,754,000 | $-72,000 |
| Change In Accrued Expense | $-1,353,000 | $356,000 | $-1,651,000 | $249,000 |
| Change In Payable | $220,000 | $-419,000 | $-103,000 | $-321,000 |
| Change In Account Payable | $220,000 | $-419,000 | $-103,000 | $-321,000 |
| Change In Prepaid Assets | $665,000 | $587,000 | $3,983,000 | $-4,197,000 |
| Stock Based Compensation | $1,023,000 | $3,195,000 | $4,948,000 | $5,228,000 |
| Asset Impairment Charge | $0 | $4,431,000 | $0 | - |
| Deferred Tax | $0 | $-84,000 | $0 | - |
| Deferred Income Tax | $0 | $-84,000 | $0 | - |
| Depreciation Amortization Depletion | $456,000 | $972,000 | $941,000 | $898,000 |
| Depreciation And Amortization | $456,000 | $972,000 | $941,000 | $898,000 |
| Depreciation | $456,000 | $972,000 | $941,000 | $898,000 |
| Gain Loss On Investment Securities | $3,161,000 | - | - | - |
| Gain Loss On Sale Of PPE | $241,000 | $0 | $1,000 | $2,000 |
| Net Income From Continuing Operations | $-10,345,000 | $-24,251,000 | $-22,942,000 | $-20,997,000 |
| Net PPE Purchase And Sale | - | $0 | $-218,000 | $-892,000 |
| Purchase Of PPE | - | $0 | $-218,000 | $-892,000 |
| Other Non Cash Items | - | $-17,000 | $107,000 | $502,000 |
Fetched: 2026-06-21